0.38
Citius Oncology, Inc.
Metrics score locked — part of Premium
FY22
FY23
FY23
FY24
FY25
FY22 – FY25
Assets
(positive)
Change from FY22 to FY25
millions USD
FY22:
FY23:
7.73
FY23:
0.06
FY24:
11.0
FY25:
27.5
(positive)
Change from FY22 to FY25
millions USD
FY22:
67.8
FY23:
40.0
FY23:
72.6
FY24:
73.4
FY25:
73.4
Total assets
Change from FY22 to FY25
millions USD
FY22:
68.2
FY23:
47.7
FY23:
72.6
FY24:
84.4
FY25:
101
Liabilities & Equity
(negative)
Change from FY22 to FY25
millions USD
FY22:
0.03
FY23:
21.0
FY23:
2.05
FY24:
32.7
FY25:
49.5
(negative)
Change from FY23 to FY25
millions USD
FY22:
–
FY23:
1.15
FY23:
–
FY24:
5.53
FY25:
6.59
(positive)
Change from FY22 to FY25
millions USD
FY22:
0.35
FY23:
25.5
FY23:
−1.99
FY24:
46.1
FY25:
44.9
Total liabilities & equity
Change from FY23 to FY25
millions USD
FY22:
–
FY23:
47.7
FY23:
–
FY24:
84.4
FY25:
101
All amounts in millions USD